Vertraagde tijd
TEL AVIV STOCK EXCHANGE
12:55:27 02-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
78
ILa
|
-1,52%
|
|
-6,36%
|
-17,46%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
21,39
|
20,64
|
55,5
|
57,32
|
27,02
|
15,87
|
Bedrijfswaarde
1 |
16,62
|
17,82
|
46,44
|
49,89
|
22,77
|
13,68
|
K/w-verhouding
|
34,2
x
|
4,66
x
|
17,6
x
|
9,97
x
|
-7,9
x
|
-0,98
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
8,39
x
|
2,83
x
|
7,47
x
|
5,4
x
|
6,49
x
|
8,59
x
|
Bedrijfswaarde/omzet
|
6,52
x
|
2,44
x
|
6,25
x
|
4,7
x
|
5,47
x
|
7,4
x
|
Bedrijfswaarde/EBITDA
|
13,1
x
|
3,67
x
|
10,4
x
|
6,97
x
|
15,5
x
|
-65,4
x
|
Bedrijfswaarde/FCF
|
7,19
x
|
5,12
x
|
7,72
x
|
8,64
x
|
13,6
x
|
25,1
x
|
FCF Yield
|
13,9%
|
19,5%
|
13%
|
11,6%
|
7,33%
|
3,98%
|
Price to Book
|
0,91
x
|
0,65
x
|
1,49
x
|
1,2
x
|
0,62
x
|
0,55
x
|
Aantal aandelen (in duizenden)
|
12.511
|
13.232
|
14.800
|
16.425
|
16.425
|
16.799
|
Referentieprijs
2 |
1,710
|
1,560
|
3,750
|
3,490
|
1,645
|
0,9450
|
Datum van publicatie
|
28/03/19
|
26/04/20
|
31/03/21
|
30/03/22
|
29/03/23
|
31/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
2,549
|
7,304
|
7,426
|
10,61
|
4,161
|
1,848
|
EBITDA
1 |
1,264
|
4,856
|
4,466
|
7,155
|
1,469
|
-0,209
|
Bedrijfsresultaat (EBIT)
1 |
1,256
|
4,852
|
4,46
|
7,147
|
1,461
|
-0,221
|
Operationele Marge
|
49,27%
|
66,43%
|
60,06%
|
67,37%
|
35,11%
|
-11,96%
|
Resultaat voor belastingen (EBT)
1 |
0,876
|
4,553
|
2,988
|
5,852
|
-3,607
|
-16,23
|
Nettowinst (verlies)
1 |
0,876
|
4,553
|
2,988
|
5,852
|
-3,607
|
-16,23
|
Nettomarge
|
34,37%
|
62,34%
|
40,24%
|
55,16%
|
-86,69%
|
-878,3%
|
WPA
2 |
0,0500
|
0,3347
|
0,2125
|
0,3500
|
-0,2083
|
-0,9600
|
Free Cash Flow
1 |
2,312
|
3,478
|
6,016
|
5,777
|
1,67
|
0,5449
|
FCF-marge
|
90,72%
|
47,62%
|
81,02%
|
54,45%
|
40,14%
|
29,48%
|
Kasstroomconversie (ebitda)
|
182,94%
|
71,62%
|
134,72%
|
80,74%
|
113,69%
|
-
|
Kasstroomconversie (nettowinst)
|
263,97%
|
76,39%
|
201,36%
|
98,72%
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
28/03/19
|
26/04/20
|
31/03/21
|
30/03/22
|
29/03/23
|
31/03/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
4,77
|
2,83
|
9,06
|
7,43
|
4,25
|
2,2
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
2,31
|
3,48
|
6,02
|
5,78
|
1,67
|
0,54
|
ROE (netto-inkomsten/eigen vermogen)
|
4,09%
|
17%
|
8,89%
|
13,8%
|
-7,78%
|
-44%
|
ROA (netto-inkomsten/totale activa)
|
3,52%
|
11%
|
8,04%
|
10,3%
|
1,93%
|
-0,36%
|
Totale activa
1 |
24,87
|
41,42
|
37,17
|
57,08
|
-186,6
|
4.459
|
Nettoactief per aandeel
2 |
1,880
|
2,400
|
2,510
|
2,910
|
2,670
|
1,720
|
Cashflow per aandeel
2 |
0,3800
|
0,2300
|
0,6100
|
0,4500
|
0,2400
|
0,1300
|
Capex
1 |
0
|
-
|
0,02
|
-
|
0,01
|
0,02
|
Capex/omzet
|
0,12%
|
-
|
0,31%
|
-
|
0,22%
|
0,81%
|
Datum van publicatie
|
28/03/19
|
26/04/20
|
31/03/21
|
30/03/22
|
29/03/23
|
31/03/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -17,46% | 3,58 mln. | | +43,36% | 54,63 mld. | | -5,31% | 39,92 mld. | | +14,75% | 26,86 mld. | | -12,56% | 26,22 mld. | | -22,45% | 18,78 mld. | | +25,12% | 12,21 mld. | | +0,04% | 12,16 mld. | | +26,04% | 11,94 mld. | | -11,83% | 10,74 mld. |
Biotechnologie & Medisch Onderzoek - Andere
|